Taysha Gene Therapies, Inc. has grown revenue 57% a year over three years and 57% a year over five. Revenue growth, 3-year annual rate: +57% (Biotechnology median +21%). Revenue growth, 5-year rate: +57%, growth has slowed since the five-year average. Years of annual history on file: 6, FY2020 to FY2025, as filed.

TSHATaysha Gene Therapies, Inc.

HealthcareUSD

$6.01

$2.7252 weeks$6.98

Is it growing?

Is TSHA growing?

Taysha Gene Therapies, Inc. has grown revenue 57% a year over three years and 57% a year over five.

+57%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +57%
Revenue growth, 5-year rate · +57% over three · growth has slowed since the five-year average
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed

Details›